For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260423:nRSW5592Ba&default-theme=true
RNS Number : 5592B Craneware plc 23 April 2026
23 April 2026
Craneware plc
("Craneware", or the "Company")
Transaction in Own Shares
Craneware (AIM: CRW.L), a leader in healthcare financial performance
solutions, announces it has purchased the following number of its Ordinary
Shares of 1p each through Joh. Berenberg, Gossler & Co. KG, London Branch
("Berenberg") on the London Stock Exchange.
Date of purchases: 17 to 22 April 2026
Aggregate number of Ordinary Shares purchased: 117,395
Lowest price paid per share (GBp): 1,486.00
Highest price paid per share (GBp): 1,542.00
Volume weighted average price paid per share (GBp): 1,512.18
The Company will hold the purchased shares in Treasury. Following the purchase
of these shares, the Company will have 34,712,101 Ordinary Shares in issue
(excluding Treasury shares), and the Company will hold 830,068 Ordinary Shares
in Treasury.
The figure of 34,712,101 represents the total voting rights in the Company and
may be used by shareholders as the denominator for calculating whether they
are required to notify their interest in, or a change to their interest in,
the Company under the FCA's Disclosure Guidance and Transparency Rules.
The table below contains detailed information about the purchases made as part
of the buyback programme which was announced by the Company on 16 March 2026
(the "Programme").
Schedule of Purchases - Individual Transactions
In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No
596/2014 as it forms part of UK law, a full breakdown of the individual trades
made by Berenberg on behalf of the Company as part of the Programme is
detailed below:
Number of ordinary shares purchased Transaction price (GBp share) Time of transaction (UK Time) Transaction Trading Venue
reference number
1,250 1,494.00 17.04.2026 08:19:38 00066420065TRLO0 LSE
2,500 1,514.00 17.04.2026 12:07:21 00066428976TRLO0 LSE
750 1,514.00 17.04.2026 12:16:37 00066429544TRLO0 LSE
2,500 1,510.00 17.04.2026 12:49:03 00066430688TRLO0 LSE
1,000 1,510.00 17.04.2026 16:00:44 00066467308TRLO0 LSE
3,096 1,510.00 17.04.2026 16:12:18 00066470585TRLO0 LSE
1,250 1,510.00 17.04.2026 16:18:31 00066472117TRLO0 LSE
3,000 1,510.00 17.04.2026 16:21:10 00066472813TRLO0 LSE
4,000 1,510.00 17.04.2026 16:33:19 00066474997TRLO0 LSE
500 1,486.00 20.04.2026 08:28:00 00066482429TRLO0 LSE
1,000 1,490.00 20.04.2026 08:30:00 00066482575TRLO0 LSE
1,250 1,489.84 20.04.2026 09:08:00 00066483861TRLO0 LSE
500 1,493.00 20.04.2026 10:26:00 00066486390TRLO0 LSE
1,750 1,500.00 20.04.2026 11:12:00 00066487795TRLO0 LSE
1,500 1,500.00 20.04.2026 11:13:00 00066487829TRLO0 LSE
3,500 1,500.00 20.04.2026 11:14:00 00066487853TRLO0 LSE
1,500 1,494.00 20.04.2026 12:08:00 00066488882TRLO0 LSE
5,000 1,495.00 20.04.2026 12:31:00 00066489554TRLO0 LSE
3,000 1,494.91 20.04.2026 13:31:00 00066492517TRLO0 LSE
876 1,500.00 20.04.2026 13:44:00 00066492829TRLO0 LSE
2,000 1,494.00 20.04.2026 14:06:00 00066493452TRLO0 LSE
5,000 1,498.75 20.04.2026 15:58:00 00066503278TRLO0 LSE
1,250 1,496.00 20.04.2026 16:04:00 00066504074TRLO0 LSE
2,000 1,494.00 20.04.2026 16:10:00 00066504737TRLO0 LSE
1,750 1,490.00 20.04.2026 16:30:00 00066508690TRLO0 LSE
2,465 1,502.00 21.04.2026 12:01:04 00066529434TRLO0 LSE
6,176 1,502.00 21.04.2026 12:14:05 00066530413TRLO0 LSE
4,248 1,514.00 21.04.2026 13:21:53 00066533180TRLO0 LSE
2,252 1,514.00 21.04.2026 13:39:09 00066533825TRLO0 LSE
22,010 1,514.00 21.04.2026 14:07:34 00066534816TRLO0 LSE
12,500 1,530.00 22.04.2026 09:01:00 00066562644TRLO0 LSE
5,000 1,530.00 22.04.2026 09:04:00 00066562995TRLO0 LSE
1,000 1,530.00 22.04.2026 09:33:00 00066565475TRLO0 LSE
9,272 1,542.00 22.04.2026 11:01:00 00066572683TRLO0 LSE
750 1,524.00 22.04.2026 11:34:00 00066573824TRLO0 LSE
For further information please contact:
Craneware
plc
+44 (0)131 550 3100
Keith Neilson, CEO
Craig Preston, CFO
Alma Strategic
Communications
+44 (0)20 3405 0205
Caroline Forde, Kinvara Verdon, Louisa
El-Ahwal
craneware@almastrategic.com
About Craneware
For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in
healthcare financial and operational transformation, delivering cutting-edge
technologies that drive measurable impact. Our Trisus® cloud ecosystem
unifies data, revenue intelligence, margin intelligence, and advanced
analytics, enabling healthcare organizations to optimize performance, improve
financial sustainability, and drive strategic growth. As a trusted Microsoft
partner, we provide future-ready solutions-including the Best in KLAS Trisus
Chargemaster - that simplify the complexities of healthcare finance and
operations. What sets us apart is our unique combination of deep healthcare
expertise and engineering excellence, positioning us as a strategic partner
rather than just a technology provider. The Craneware Group empowers
healthcare organizations to achieve sustainable financial success while
delivering better outcomes for the communities they serve - today and in the
future. Together, we are transforming the business of healthcare.
Learn more at www.thecranewaregroup.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSPPUQWCUPQGMP
Copyright 2019 Regulatory News Service, all rights reserved